Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible?

Published:2018-09 Issue:9 Volume:18 Page:e282-e287
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Cox Helen,Hughes Jennifer,Black John,Nicol Mark P

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference50 articles.

1. A new initiative on precision medicine;Collins;N Engl J Med,2015

2. Public health in the precision-medicine era;Bayer;N Engl J Med,2015

3. Digital health for the End TB strategy: an agenda for action,2015

4. The End TB strategy: global strategy and targets for tuberculosis prevention, care and control after 2015,2015

5. Global tuberculosis report 2016,2016

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach;Nature Communications;2024-01-12

2. The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis;Clinical Infectious Diseases;2023-10-24

3. Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach;2023-10-02

4. What’s New in the Molecular Diagnosis of Childhood Tuberculosis?;Pediatric Infectious Disease Journal;2023-07-13

5. Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients;Journal of Clinical Microbiology;2023-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3